Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.27% | 32.27% | -2,414.14% | 27.79% | -20.06% |
| Total Depreciation and Amortization | -31.05% | -27.95% | -1.81% | -2.90% | -4.16% |
| Total Amortization of Deferred Charges | 0.00% | 2.56% | 0.00% | 25.81% | 39.29% |
| Total Other Non-Cash Items | -106.22% | -1,908.00% | 85.22% | -22.00% | 59.77% |
| Change in Net Operating Assets | -411.40% | 97.43% | -27.24% | -68.41% | -116.07% |
| Cash from Operations | -134.00% | 78.81% | -428.43% | 31.59% | -48.72% |
| Capital Expenditure | 38.10% | -1,541.94% | 117.68% | 72.55% | 70.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 38.10% | -1,541.94% | 117.68% | 72.55% | 70.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 12.82% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 12.82% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.10% | -29.70% | -864.23% | 51.58% | 157.35% |